Detection of previously unidentified metastatic disease as a leading cause of screening failure in a phase III trial of zibotentan versus placebo in patients with nonmetastatic, castration resistant prostate cancer
| Image |  |
|---|---|
| Description | scientific article published on 12 May 2012 |
| Author/s |
author: Celestia Higano Karim Fizazi |
| Publication date | May 12, 2012 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |